Shandong Weigao Group repurchases shares, adjusts capital

Shandong Weigao Group Medical Polymer Company Limited submitted a Next Day Disclosure Return on December 4, 2025, detailing a repurchase of its H-shares. On December 4, 2025, the company repurchased 74,000 shares on the exchange at prices ranging from HK$5.47 to HK$5.59 per share, totaling an aggregate price of HK$410,120. These repurchased shares will be held as treasury shares.

Following the repurchase, the number of issued shares (excluding treasury shares) decreased by 74,000, representing 0.0016% of the existing number of issued shares before the event. The opening balance of issued shares as of December 3, 2025, was 4,494,797,124, with 27,535,200 treasury shares. The closing balance on December 4, 2025, reflects 4,494,723,124 issued shares and 27,609,200 treasury shares.

The repurchase was made under a mandate granted on May 27, 2025, authorizing the repurchase of up to 451,560,392 shares. With this transaction, the cumulative number of shares repurchased on the exchange stands at 20,960,800, which represents 4.6419% of the issued shares (excluding treasury shares) as of the resolution date. A moratorium period for new share issues or treasury share sales is in effect until January 3, 2026.